Pune, Maharashtra -- (SBWIRE) -- 02/16/2019 -- Fact.MR, in its recent study, projects the global liver cancer diagnostics market to register a steady expansion at 5.5% CAGR during the forecast period 2017 to 2022. In 2017, the global market for liver cancer diagnostics is expected to reach nearly US$ 700 Mn in revenues.

Liver cancer, or, hepatocellular carcinoma (HCC) has been observed to cause a large number of deaths annually. In a bid to prevent liver cancer from reaching the final stage, scientists around the world have developed a slew of improved diagnostic solutions. Newer techniques are being developed for the diagnosis of hepatocellular carcinoma, rendering both partial hepatectomy, and liver transplant safer and more effective. Global leading medical instrument manufaturers are focusing on the development of new novel instruments in order to diagnose liver cancer completely. These factors are estimated to drive growth of the global liver cancer diagnostics market during the forecast period.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=73

North America to Remain Dominant in the Global Liver Cancer Diagnostics Market

North America is expected to remain dominant in the global liver cancer diagnostics market, in terms of revenues. In addition, the markets for liver cancer diagnostics in North America and Europe are estimated to exhibit a parallel expansion at 5.6% CAGR through 2022. In contrast, markets in Japan and MEA are expected to exhibit a sluggish expansion during the forecast period.

Based on test type, biopsy test segment is expected to register the highest CAGR in the market through 2022, followed by LFTs. AFP test is estimated to remain preferred for liver cancer diagnostics in the global market. Revenue from AFP test is expected to account for over half share of the market in 2017, and is estimated to gain 52 BPS in its market share between 2017 and 2022.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=73

Hospital-associated Labs to Remain Sought-after for Liver Cancer Diagnostics

Hospital-associated labs will continue to be sought-after for liver cancer diagnostics across the globe. Liver cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end. Independent diagnostic laboratories will remain the second most lucrative end-users in the global liver cancer diagnostics market. In addition, liver cancer diagnostics in cancer research institutes are expected to register the fastest expansion over the forecast period.

Competition Tracking

The report has also profiled leading players in the global liver cancer diagnostics market, which include Illumina, Inc., Foundation Medicine, Inc., Danaher Corporation
Sysmex Corporation, and Biocept, Inc.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=73

Table of Content Covered in the report are:

1. Global Liver Cancer Diagnostics Market - Executive Summary

2. Global Liver Cancer Diagnostics Market Overview
2.1. Introduction
2.1.1. Global Liver Cancer Diagnostics Market Taxonomy
2.1.2. Global Liver Cancer Diagnostics Market Definition
2.2. Global Liver Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Liver Cancer Diagnostics Market Y-o-Y Growth
2.3. Global Liver Cancer Diagnostics Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region

Access This Report @ https://www.factmr.com/checkout/73/S

3. Global Liver Cancer Diagnostics Market Analysis and Forecast By Test Type
3.1. Global Liver Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022
3.1.1. AFP Tests Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. LFTs Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. Biopsy Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
3.1.4. Other Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.4.1. Revenue (US$ Mn) Comparison, By Region
3.1.4.2. Market Share Comparison, By Region
3.1.4.3. Y-o-Y growth Comparison, By Region

4. Global Liver Cancer Diagnostics Market Analysis and Forecast By End User
4.1. Global Liver Cancer Diagnostics Market Size and Forecast By End User, 2012-2022
4.1.1. Hospital Associated Labs Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Independent Diagnostic Laboratories Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Cancer Research Institutes Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Others Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region

5. Global Liver Cancer Diagnostics Market Analysis and Forecast By Region
5.1. Global Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
5.1.1. North America Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.1.2. Revenue (US$ Mn) Comparison, By End User
5.1.2. Latin America Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.2.2. Revenue (US$ Mn) Comparison, By End User
5.1.3. Europe Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.3.2. Revenue (US$ Mn) Comparison, By End User
5.1.4. Japan Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.4.2. Revenue (US$ Mn) Comparison, By End User
5.1.5. APEJ Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.5.2. Revenue (US$ Mn) Comparison, By End User
5.1.6. MEA Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type
5.1.6.2. Revenue (US$ Mn) Comparison, By End User

6. North America Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
6.1.1. Revenue (US$ Mn) Comparison, By Test Type
6.1.2. Revenue (US$ Mn) Comparison, By End User
6.2. Canada Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
6.2.1. Revenue (US$ Mn) Comparison, By Test Type
6.2.2. Revenue (US$ Mn) Comparison, By End User

And Continue...

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Web: https://www.factmr.com/ 
Read Industry News at - https://theswisstimes.com